Quantitation of Azoles and Echinocandins in Compartments of Peripheral Blood by Liquid Chromatography-Tandem Mass Spectrometry

被引:76
作者
Farowski, Fedja [1 ]
Cornely, Oliver A. [1 ,2 ]
Vehreschild, Joerg J. [1 ]
Hartmann, Pia [3 ]
Bauer, Tim [4 ]
Steinbach, Angela [1 ]
Rueping, Maria J. G. T. [1 ]
Mueller, Carsten [4 ]
机构
[1] Klinikum Univ Koln, Innere Med Klin 1, Klin Studienzentrum Infektiol 2, D-50924 Cologne, Germany
[2] Univ Cologne, ZKS Koln, BMBF 01KN0706, D-50924 Cologne, Germany
[3] Univ Cologne, Innere Med Klin 1, D-50924 Cologne, Germany
[4] Klinikum Univ Koln, Inst Pharmakol, D-50924 Cologne, Germany
关键词
ANTIFUNGAL TRIAZOLE BAL4815; FULLY AUTOMATED-ANALYSIS; INTRACELLULAR ACTIVITY; DOSE PHARMACOKINETICS; ORAL POSACONAZOLE; ADVERSE EVENTS; LC-LC; VORICONAZOLE; SAFETY; DRUG;
D O I
10.1128/AAC.01276-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A rapid turnaround is a prerequisite of therapeutic drug monitoring (TDM). For antifungals, this need is still unmet, since hardly any method has been established to simultaneously quantitate concentrations of different antifungal classes. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed allowing quantitation of anidulafungin (ANF), caspofungin (CSF), isavuconazole (ISC), micafungin (MCF), posaconazole (PSC), and voriconazole (VRC). Quantitation was successful with diluted plasma samples, peripheral blood mononuclear cells (PBMC), polymorphonuclear leukocytes (PMN), and erythrocytes (RBC). A triple quadrupole mass spectrometer in selected reaction monitoring mode was used with positive electrospray ionization. Cells and calibration standards were extracted with acetonitrile containing internal standard. Internal standards were a CSF derivate for echinocandins and itraconazole for triazoles. Chromatographic separation of the supernatant was achieved by a gradient method facilitating a BetaBasic C4 column. Analytes were quantified in a single 8-min run. Calibration curves were linear and fitted using least squares with a weighting factor of the reciprocal concentration. Limits of detection (ng/ml) were ANF, 8.3; CSF, 31.5; ISC, 1.5; MCF, 97.7; PSC, 3.3; and VRC, 1.4. The lower limits of quantitation (ng/ml) were ANF, 64; CSF, 108; ISC, 4.5; MCF, 160; PSC, 10; and VRC, 4.2. Intraday precisions ranged from 6.3% to 8.8% for azoles and 8.8% to 15.4% for echinocandins. Intraday and interday accuracies (percent bias) of all analytes were within 13.8%. The method was established as standard practice for the quantitation of intracellular antifungal concentrations and optimizes TDM by applying a rapid single method for 6 antifungals.
引用
收藏
页码:1815 / 1819
页数:5
相关论文
共 39 条
[31]   Multiple-dose pharmacokinetics and safety of the new antifungal triazole BAL4815 after intravenous infusion and oral administration of its prodrug, BAL8557, in healthy volunteers [J].
Schmitt-Hoffmann, A ;
Roos, B ;
Maares, J ;
Heep, M ;
Spickerman, J ;
Weidekamm, E ;
Brown, T ;
Roehrle, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :286-293
[32]  
Smith D, 2008, THER DRUG MONIT, V30, P167, DOI 10.1097/FTD.0b013e318167d0e0
[33]   Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities [J].
Tan, K ;
Brayshaw, N ;
Tomaszweski, K ;
Troke, P ;
Wood, N .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (02) :235-243
[34]   Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients [J].
Trifilio, Steve ;
Pennick, Gennethel ;
Pi, Judy ;
Zook, Jennifer ;
Golf, Mary ;
Kaniecki, Kimberley ;
Singhal, Seema ;
Williams, Stephanie ;
Winter, Jane ;
Tallman, Martin ;
Gordon, Leo ;
Frankfurt, Olga ;
Evens, Andrew ;
Mehta, Jayesh .
CANCER, 2007, 109 (08) :1532-1535
[35]   Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection [J].
Ullmann, AJ ;
Cornely, OA ;
Burchardt, A ;
Hachem, R ;
Kontoyiannis, DP ;
Töpelt, K ;
Courtney, R ;
Wexler, D ;
Krishna, G ;
Martinho, M ;
Corcoran, G ;
Raad, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) :658-666
[36]   Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial [J].
Walsh, Thomas J. ;
Raad, Issam ;
Patterson, Thomas F. ;
Chandrasekar, Pranatharthi ;
Donowitz, Gerald R. ;
Graybill, Richard ;
Greene, Reginald E. ;
Hachem, Ray ;
Hadley, Susan ;
Herbrecht, Raoul ;
Langston, Amelia ;
Louie, Arnold ;
Ribaud, Patricia ;
Segal, Brahm H. ;
Stevens, David A. ;
van Burik, Jo-Anne H. ;
White, Charles S. ;
Corcoran, Gavin ;
Gogate, Jagadish ;
Krishna, Gopal ;
Pedicone, Lisa ;
Hardalo, Catherine ;
Perfect, John R. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (01) :2-12
[37]  
YUSUHIRO Y, 2002, JPN J CHEMOTHER, V50, P68
[38]   Determination of voriconazole in aqueous humor by liquid chromatography-electrospray ionization-mass spectrometry [J].
Zhou, L ;
Glickman, RD ;
Chen, N ;
Sponsel, WE ;
Graybill, JR ;
Lam, KW .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 776 (02) :213-220
[39]   Hallucinations during voriconazole therapy [J].
Zonios, Dimitrios I. ;
Gea-Banacloche, Juan ;
Childs, Richard ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 (01) :E7-E10